A landmark epidemiological analysis tracking 255,830 person-years of follow-up data has produced striking findings: total testosterone, despite its prominence in clinical practice, was not the strongest hormonal predictor of mortality among aging men. The study measured five distinct hormonal markers across the full cohort observation period, allowing direct comparison of their independent predictive power.
This substantial dataset provides robust evidence that non-testosterone hormonal pathways exert greater influence on male mortality outcomes than conventional wisdom suggests. The extended follow-up period strengthens the reliability of these findings, capturing sufficient mortality events to establish meaningful associations.
These results challenge clinicians to reconsider single-hormone assessment strategies and adopt broader endocrine profiling approaches for comprehensive risk stratification in male patients.
Read the full article on GMJ Newsroom.
Was this article helpful?
